Professor Simon L. Croft



Simon L. Croft, BSC, PGCE, PHD, FRSB, is Professor of Parasitology and Head of the Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine. Mr. Croft has extensive experience and knowledge in antimicrobial and antiprotozoal therapies and supports the adoption of in vitro experimental models for drug discovery and development for infectious diseases. He served as a Senior Scientific Advisor at Invitrocue Limited since May 20, ... 2016 until June 14, 2017. He serves as a Member of Scientific Advisory Board at reViral Ltd. His expertise and knowledge on antimicrobial chemotherapy was developed while working for 5 years with the Wellcome Research Laboratories, Beckenham, UK in the 1980s. Following his return to academia, he focused his research on the identification and evaluation of novel drugs and formulations for the treatment of leishmaniasis, malaria, human African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease). This research included projects on miltefosine, AmBisome and topical paromomycin, all of which reached clinical trials for the treatment of leishmaniasis and many others with academic and industry partners. His work on anti-malarials has included several MMV supported discovery and pre-clinical projects. Current research interests include drug - immune response interactions and PK PD relationships. From 2004 to 2007, he was the First Research & Development Director of the Drugs for Neglected Diseases Initiative (DNDi), Geneva. Mr. Croft trained at the Liverpool School of Tropical Medicine and after Post-Doctoral periods in the laboratory researching drug mechanisms and in disease endemic countries working on the transmission of African trypanosomiasis, he moved to research on drug discovery and development.